Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Xiaoying Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8382-9719; OpenAlex author ID A5101873697. Sources: OpenAlex.

Their work

Papers
13
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2021: 2 papers · 2022: 4 papers · 2023: 5 papers · 2024: 2 papers

Papers 13

  1. IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling. Co-author DOI 10.1007/s13402-024-00925-x↗
  2. MLPH regulates EMT in pancreatic adenocarcinoma through the PI3K-AKT signaling pathway. Co-author DOI 10.7150/jca.94573↗
  3. Retraction Note: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling. Co-author DOI 10.1007/s13402-023-00897-4↗
  4. Prognostic value and immune infiltration of ARMC10 in pancreatic adenocarcinoma via integrated bioinformatics analyses. Co-author DOI 10.1016/j.heliyon.2023.e20464↗
  5. STOML2 restricts mitophagy and increases chemosensitivity in pancreatic cancer through stabilizing PARL-induced PINK1 degradation. Co-author DOI 10.1038/s41419-023-05711-5↗
  6. EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway. Co-author DOI 10.1186/s12967-023-04043-4↗
  7. Pancreatic cancer stemness: dynamic status in malignant progression. Co-author DOI 10.1186/s13046-023-02693-2↗
  8. CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway. Co-author DOI 10.1186/s12935-022-02768-8↗
  9. Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs. Co-author DOI 10.1186/s12935-022-02785-7↗
  10. Multidrug resistance genes screening of pancreatic cancer based on sensitivity profile to chemotherapeutic drugs Co-author DOI 10.21203/rs.3.rs-1759071/v2↗
  11. Long Noncoding RNA and Circular RNA: Two Rising Stars in Regulating Epithelial-Mesenchymal Transition of Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.910678↗
  12. Mobius strip in pancreatic cancer: biogenesis, function and clinical significance of circular RNAs. Co-author DOI 10.1007/s00018-021-03908-5↗
  13. IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling. Co-author DOI 10.1007/s13402-021-00651-8↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bangbo Zhao · 12 shared papers, 2021–2024 · strength 2.06
  2. Yuanyang Wang · 12 shared papers, 2021–2024 · strength 2.06
  3. Zeru Li · 12 shared papers, 2021–2024 · strength 2.06
  4. Weibin Wang · 10 shared papers, 2021–2024 · strength 1.68
  5. Cheng‐Feng Qin · 7 shared papers, 2021–2024 · strength 1.19
  6. Tianyu Li · 6 shared papers, 2022–2023 · strength 1.05
  7. Tianhao Li · 5 shared papers, 2021–2024 · strength 0.84
  8. Yutong Zhao · 4 shared papers, 2022–2023 · strength 0.74
  9. Xingtong Zhou · 4 shared papers, 2021–2024 · strength 0.71
  10. Tianhao Li · 4 shared papers, 2022–2023 · strength 0.64
  11. Cheng Qin · 3 shared papers, 2022–2023 · strength 0.53
  12. Weibin Wang · 2 shared papers, 2023 · strength 0.39
  13. Cheng Yong Qin · 2 shared papers, 2022–2023 · strength 0.34
  14. Lei Tian · 1 shared paper, 2024 · strength 0.23
  15. Mengda Wei · 1 shared paper, 2024 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.